About
QV Bioelectronics is a medical device startup located in Alderley Park, Cheshire, UK. The company focuses on developing innovative implanted technology to treat glioblastoma, a challenging form of brain cancer. Founded by Dr. Chris Bullock, a biomedical engineer, and Dr. Richard Fu, a neurosurgeon, QV Bioelectronics aims to enhance the quality of life for brain tumor patients through electric field therapy. The flagship product, the GRACE implant, is an experimental bioelectronic device designed to deliver continuous electric field therapy to tumor resection margins, where glioblastoma often recurs. This therapy aims to disrupt cancer cell growth cycles and slow tumor progression. Currently, QV Bioelectronics is working on a prototype of the GRACE implant and is preparing for a first-in-man clinical trial. The company combines expertise in advanced materials and neurosurgery to create a device that can provide electrotherapy around the clock without affecting patient quality of life.
Technologies
Keywords
Company Information
-
Employees 16
-
Founded 2018
-
Annual Revenue $2000000
-
Total Funding $6401902
Location
England, United Kingdom, SK10 4TF